2020
DOI: 10.1007/s00381-020-04672-w
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of anticoagulation and antiplatelet therapy for treatment of blunt cerebrovascular injury in children <10 years of age: a multicenter retrospective cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…Our case supports a role for PED-Shield in the endovascular armamentarium available to address ruptured pseudoaneurysms. The use of antiplatelet therapy in children is commonplace 23 and believed to be safe in the setting of blunt cerebrovascular injury, 24,25 but there is little evidence regarding the lifelong implications of these medications in children, which certainly requires further inquiry.…”
Section: Discussionmentioning
confidence: 99%
“…Our case supports a role for PED-Shield in the endovascular armamentarium available to address ruptured pseudoaneurysms. The use of antiplatelet therapy in children is commonplace 23 and believed to be safe in the setting of blunt cerebrovascular injury, 24,25 but there is little evidence regarding the lifelong implications of these medications in children, which certainly requires further inquiry.…”
Section: Discussionmentioning
confidence: 99%
“…After full text analysis, 17 articles were included in the review. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] The incidence of BCVI in children was reported to be 0.03% to 1.30% of blunt traumatic injuries. 15,17 The strongest predictors for BCVI were the presence of basal skull fracture, cervical spine fracture, intracranial hemorrhage, Glasgow Coma Scale score less than 8, mandible fracture, and injury severity score more than 15.…”
Section: Resultsmentioning
confidence: 99%
“…Other studies likewise report no difference in BCVI outcomes depending on antithrombotic regimen used. 25,26 At our center, most patients with BCVI, regardless of grade, were initiated on high-dose aspirin as antithrombotic therapy; however, by a statistically significant margin, those with lower-grade injuries were more frequently initiated on low-dose aspirin. BCVI management is not currently protocolized at our institution, and treatment decisions are made at the discretion of the on-service attending neurosurgeon.…”
Section: Common Care Patterns In-hospital Anticoagulation Vs Antiplat...mentioning
confidence: 98%